| Immune activation in patients with irritable bowel syndrome T Liebregts, B Adam, C Bredack, A Röth, S Heinzel, S Lester, ... Gastroenterology 132 (3), 913-920, 2007 | 834 | 2007 |
| Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes AH MacLennan, JL Broadbent, S Lester, V Moore Cochrane database of systematic reviews, 2004 | 829 | 2004 |
| Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome CJ Lessard, H Li, I Adrianto, JA Ice, A Rasmussen, KM Grundahl, JA Kelly, ... Nature genetics 45 (11), 1284-1292, 2013 | 554 | 2013 |
| Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review A MacLennan, S Lester, V Moore Climacteric 4 (1), 58-74, 2001 | 253 | 2001 |
| Oral oestrogen replacement therapy versus placebo for hot flushes. A MacLennan, S Lester, V Moore The Cochrane database of systematic reviews, CD002978-CD002978, 2001 | 252 | 2001 |
| Oral oestrogen replacement therapy versus placebo for hot flushes. A MacLennan, S Lester, V Moore The Cochrane database of systematic reviews, CD002978-CD002978, 2001 | 252 | 2001 |
| Genomic diversity of natural killer cell receptor genes in three populations M Toneva, V Lepage, G Lafay, N Dulphy, M Busson, S Lester, A Vu‐Trien, ... Tissue antigens 57 (4), 358-362, 2001 | 240 | 2001 |
| Clinical and genetic associations of autoantibodies to 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme a reductase in patients with immune‐mediated myositis and necrotizing myopathy V Limaye, C Bundell, P Hollingsworth, A Rojana‐Udomsart, F Mastaglia, ... Muscle & nerve 52 (2), 196-203, 2015 | 157 | 2015 |
| A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis Y Hao, V Thakkar, W Stevens, K Morrisroe, D Prior, C Rabusa, P Youssef, ... Arthritis research & therapy 17, 1-11, 2015 | 122 | 2015 |
| Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells SL Heatley, G Pietra, J Lin, JML Widjaja, CM Harpur, S Lester, J Rossjohn, ... Journal of Biological Chemistry 288 (12), 8679-8690, 2013 | 121 | 2013 |
| GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways E López-Isac, M Acosta-Herrera, M Kerick, S Assassi, AT Satpathy, ... Nature communications 10 (1), 4955, 2019 | 119 | 2019 |
| Interpretation of an extended autoantibody profile in a well‐characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis KA Patterson, PJ Roberts‐Thomson, S Lester, JA Tan, P Hakendorf, ... Arthritis & Rheumatology 67 (12), 3234-3244, 2015 | 115 | 2015 |
| South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome SW Graf, P Hakendorf, S Lester, K Patterson, JG Walker, MD Smith, ... International journal of rheumatic diseases 15 (1), 102-109, 2012 | 110 | 2012 |
| HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS) M Rischmueller, S Lester, Z Chen, G Champion, R Van Den Berg, R Beer, ... Clinical & Experimental Immunology 111 (2), 365-371, 1998 | 106 | 1998 |
| Canine DLA diversity: 1. New alleles and haplotypes LJ Kennedy, A Barnes, A Short, JJ Brown, S Lester, J Seddon, L Fleeman, ... Tissue antigens 69, 272-288, 2007 | 89 | 2007 |
| Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation MD Varney, S Lester, J McCluskey, X Gao, BD Tait Human immunology 60 (6), 532-538, 1999 | 88 | 1999 |
| The IRF5–TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share LC Kottyan, EE Zoller, J Bene, X Lu, JA Kelly, AM Rupert, CJ Lessard, ... Human molecular genetics 24 (2), 582-596, 2015 | 87 | 2015 |
| Polymorphism in the 5′ regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjögren … JC Nossent, S Lester, D Zahra, CR Mackay, M Rischmueller Rheumatology 47 (9), 1311-1316, 2008 | 85 | 2008 |
| Survival in scleroderma: results from the population‐based South Australian Register P Hissaria, S Lester, P Hakendorf, R Woodman, K Patterson, C Hill, ... Internal medicine journal 41 (5), 381-390, 2011 | 82 | 2011 |
| The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis V Limaye, C Luke, G Tucker, C Hill, S Lester, P Blumbergs, ... Rheumatology international 33, 965-971, 2013 | 80 | 2013 |
